T
Taryn A. Schiripo
Researcher at Harvard University
Publications - 7
Citations - 1813
Taryn A. Schiripo is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Missense mutation. The author has an hindex of 7, co-authored 7 publications receiving 1708 citations.
Papers
More filters
Journal ArticleDOI
salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines
Nicolas Tapon,Kieran F. Harvey,Daphne W. Bell,Doke C.R. Wahrer,Taryn A. Schiripo,Daniel A. Haber,Iswar K. Hariharan +6 more
TL;DR: Salvador restricts cell numbers in vivo by functioning as a dual regulator of cell proliferation and apoptosis.
Journal ArticleDOI
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
Amy E. Roberts,Toshiyuki Araki,Kenneth D. Swanson,Kate Montgomery,Taryn A. Schiripo,Victoria A. Joshi,Li Li,Yosuf Yassin,Alex M. Tamburino,Benjamin G. Neel,Raju Kucherlapati +10 more
TL;DR: SOS1 mutants are identified as a major cause of Noonan syndrome, representing the first example of activating GEF mutations associated with human disease and providing new insights into RAS-GEF regulation.
Journal Article
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Sean Bong Lee,Sang Hyon Kim,Daphne W. Bell,Doke C.R. Wahrer,Taryn A. Schiripo,Melissa M. Jorczak,Dennis C. Sgroi,Judy Garber,Frederick P. Li,Kim E. Nichols,Jenny M. Varley,Andrew K. Godwin,Kristen M. Shannon,Ed Harlow,Daniel A. Haber +14 more
TL;DR: The observations support the functional significance of CHK2 mutations in rare cases of LFS and suggest that such mutations may substitute for inactivation of TP53.
Journal ArticleDOI
Precise Genetic Mapping and Haplotype Analysis of the Familial Dysautonomia Gene on Human Chromosome 9q31
Anat Blumenfeld,Susan A. Slaugenhaupt,Christopher B. Liebert,Violeta Temper,Channa Maayan,Sandra Gill,Diane Lucente,Maria Idelson,Kathy MacCormack,Mary Anne Monahan,James Mull,Maire Leyne,Marc L. Mendillo,Taryn A. Schiripo,Esther Mishori,Xandra O. Breakefield,Felicia B. Axelrod,James F. Gusella +17 more
TL;DR: It is now possible to provide accurate genetic testing both for families with FD and for carriers, on the basis of close flanking markers and the capacity to identify >98% of FD chromosomes by their haplotype.
Journal ArticleDOI
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
Daphne W. Bell,Sang H. Kim,Andrew K. Godwin,Taryn A. Schiripo,Patricia L. Harris,Sara M. Haserlat,Doke C.R. Wahrer,Christopher A. Haiman,Mary B. Daly,Kristin B. Niendorf,Matthew R. Smith,Dennis C. Sgroi,Judy Garber,Olufunmilayo I. Olopade,Loic Le Marchand,Brian E. Henderson,David Altshuler,David Altshuler,Daniel A. Haber,Matthew L. Freedman,Matthew L. Freedman +20 more
TL;DR: The findings highlight the notion that clinical testing for rare missense mutations within CHEK2 may have limited value in predicting breast cancer risk, but that testing for the 1100delC variant may be valuable in phenotypically‐ and geographically‐selected populations.